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Abstract 
Hairy cell leukemia (HCL) is an uncommon chronic lymphoproliferative disorder and 
accounts for around 2% of all forms of leukemias. The association of HCL with other 
neoplasms, mainly non-Hodgkin’s lymphomas, is well known. However, the simultaneous 
diagnosis of HCL and Kaposi’s sarcoma is rare, with only few cases of such an association 
having been reported. We describe a 42-year-old male patient with a well characterized 
HCL and in whom HIV-negative Kaposi’s sarcoma of the lymph node was detected. 
 
Introduction 
Hairy cell leukemia (HCL) is an uncommon chronic lymphoproliferative disorder and 
accounts for around 2% of all forms of leukemias [1]. The disease is characterized by a 
variable degree of splenomegaly, pancytopenia, and infiltration of the bone marrow with 
lymphocytes that have irregular cytoplasmic projections when identified in the peripheral 
blood. Kaposi’s sarcoma (KS) is a tumor caused by human herpesvirus-8 (HHV-8), also 
known as KS-associated herpesvirus. It is a systemic disease which can present with 
cutaneous lesions with or without visceral involvement. The cutaneous lesions can be 
solitary, localized or disseminated. KS can involve the oral cavity, lymph nodes, and 
viscera. KS can be seen in iatrogenically immunosuppressed patients and was Case Rep Oncol 2011;4:439–444 
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documented in association with lymphoproliferative disorders including HCL. Here we 
report a patient synchronously who was diagnosed with both HCL and HIV-negative KS 
of the lymph node and who died of bacterial meningitis. 
Case Report 
A 42-year-old man was referred to the medical oncology department with bilateral palpable inguinal 
lymphadenopathies persisting for 1 month. His medical history was unremarkable and he did not have 
any constitutional symptoms. He was fit and the physical examination revealed pallor, palpable 
splenomegaly at 3 cm below the left costal margin and bilateral posterior cervical and inguinal 
lymphadenopathies of 1 cm in diameter. He had neither skin nor mucosal lesions. Laboratory 
investigations revealed a hemoglobin of 6.7 g/l (Hct: 20.3%, MCV: 93.7 fl, Rtc: 2.3%), white-blood cell 
count of 2.6 × 10
9/l (neutrophils 0.1 × 10
9/l, lymphocytes 2.0 × 10
9/l, monocytes 0.05 × 10
9/l), and a 
platelet count of 37 × 10
9/l, erythrocyte sedimentation rate (ESH): 110 mm/h, LDH: 169 U/l, beta-2 
microglobulin: 2,931 ng/ml, haptoglobin: 153 mg/dl, direct antiglobulin (Coombs) test: positive, and 
indirect Coombs test: negative. The IgA and IgG levels were within the normal ranges (IgA: 188 mg/dl, 
IgG: 1,470 mg/dl), but IgM was slightly decreased (31.8 mg/dl). The thoracic computed tomography 
(CT) showed lymphadenopathies with diameters of 1.5 cm in the bilateral axillary, supraclavicular, 
mediastinal and retrocrural regions. There were lymphadenopathies of 2 cm in diameter in the 
retrocrural, paraaortic, peripancreatic and inguinal regions and splenomegaly in abdomen CT. 
In the histopathological examination of the excisional lymph node biopsy from the left inguinal 
lymph node, the normal structure of the lymph node did not exist and it was infiltrated with a tumor in 
diffuse and nodular pattern. The tumor cells had spindle-shaped nuclei with fasciculi formation (fig. 
1a), and the immunohistochemistry of the tumor cells showed CD31 positivity and they were CD20, 
CD23, S-100, CD68 and CD45RO negative. The dendritic cells were positive for CD23I in the lymph 
follicles other than the tumor-invaded areas. With all these findings the diagnosis was KS. The patient 
was negative for human immunodeficiency virus (HIV), and HHV-8 positivity was detected by nested 
polymerase chain reaction (PCR) from the blood. The lymph node biopsy specimen which was 
consistent with KS showed positive immunostaining with anti-HHV-8 antibody (fig. 1b). 
Peripheral blood film showed normochromic red cells, absolute monocytopenia, atypical lymphoid 
cells with surface projections – ‘hairy cells’ and thrombocytopenia (fig. 2). Flow cytometry from the 
peripheral blood was done and the atypical lymphocytes showed strong expression of CD11c, CD103, 
CD25, CD20, CD22, and CD19. The cells were negative for CD5, CD23, CD34, CD10, and myeloid 
markers. A diagnosis of HCL was made. The bone marrow biopsy revealed an interstitial and diffuse 
infiltrate of atypical cells with widely spaced, small, round or bean-shaped nuclei, abundant cytoplasm 
and prominent cell borders that produced the classical ‘fried egg’ appearance (fig. 3a). The atypical cells 
were CD20 positive (fig. 3b), and an increase in reticulin fibers was also seen (fig. 3c), and tartrate-
resistant acid phosphatase (TRAP) was found to be positive in the bone marrow (fig. 3d). The bone 
marrow biopsy was negative for anti-HHV-8 antibody immunostaining. 
A very short time period after the diagnostic process, before any specific treatment was initiated, the 
patient’s disease was complicated by bacterial meningitis and he died. 
Discussion 
HCL is an uncommon chronic lymphoproliferative disorder. Splenomegaly is 
common, sometimes may be massive and is found in approximately 90% of the patients 
with HCL [2]. Unlike many other lymphoproliferative disorders, peripheral 
lymphadenopathy is uncommon in HCL, with less than 10% of patients presenting with 
peripheral nodes larger than 2 cm in diameter. Although adenopathy is not common at 
diagnosis, internal lymphadenopathy(ies) may develop after a prolonged disease course 
and is present in 75% of patients at autopsy [3–5]. Our patient was admitted to the 
medical oncology department with peripheral inguinal lymphadenopathy, and he had Case Rep Oncol 2011;4:439–444 
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internal lymphadenopathies as well, so a lymph node biopsy was performed since 
lymphoproliferative disorder was thought to be the case. But the lymph node biopsy 
revealed KS. KS may be associated with pancytopenia due to HHV-8 viremia, bone 
marrow infiltration or hemophagocytosis [6, 7]. Our patient had pancytopenia but did 
not have bone marrow infiltration of KS or hemophagocytosis in the bone marrow. The 
peripheral blood and bone marrow studies showed HCL as an additional malignancy. 
If this patient was admitted to a hematology department first, the focus could be on the 
pancytopenia and HCL might be the initial diagnosis, and the lymphadenopathies would 
be attributed to the lymphoproliferative disorder so a lymph node biopsy would not be 
done. Since the diagnosis of KS came with the lymph node biopsy, a lymph node biopsy 
should be kept in mind in patients with HCL who have peripheral lymphadenopathy(ies). 
The patient was HIV negative and positive for HHV-8 (both serologically and by anti-
HHV-8 antibody immunostaining within the lymph node), which is shown to be 
responsible in the pathogenesis of KS [8]. 
An association has been noticed between HCL and other malignancies, although the 
link is controversial. A number of studies have demonstrated an increased incidence of 
secondary tumors in HCL, including melanoma, prostate cancer, gastrointestinal cancers, 
non-Hodgkin’s lymphoma, and non-melanomatous skin cancers [9, 10]. It is not clear 
whether HCL itself increases the risk or whether the therapy plays a role. Our patient had 
HCL and KS synchronously, so he did not receive any therapy that may play a role in the 
development of a second malignancy. Although there are reports indicating the 
association between HCL and KS [11, 12], to our knowledge, this is the first case 
presented in the English literature who developed HCL and KS synchronously. 
Although diagnosed synchronously, our patient most probably had HCL for a longer 
period of time, and it could be speculated that the cause of the KS in this case was the 
immunosuppressive state due to HCL. 
KS may involve lymph nodes [13], and the coexistence of KS with the other 
lymphoproliferative disorders such as chronic lymphocytic leukemia, Hodgkin’s 
lymphoma, and Castleman’s disease in the same lymph node had been published before 
[14–16]. In the present case the lymph node biopsy did not show any findings for HCL. 
Autoimmune hemolytic anemia (AIHA) have been previously described in association 
with KS [17]. Our patient had a positive DAT but no signs of AIHA. Patients with KS 
acquire numerous opportunistic infections including cytomegalovirus and Pneumocystis 
jirovecii [18]. HCL is also associated with an increased incidence of serious infections. 
The factors predisposing to infection in HCL include neutropenia, monocytopenia, 
administration of corticosteroids, splenectomy and possibly defective cell-mediated 
immune responsiveness [19–21]. Patients with KS and HCL, regardless of the underlying 
or associated disease process, may be at increased risk for developing opportunistic 
infections and should be monitored for these complications [12]. This case had 
neutropenia and monocytopenia, did not have splenectomy or receive steroids and his 
disease was complicated by bacterial meningitis and he died before any specific treatment 
against the malignancies could be administered. 
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Fig. 1. Elongated spindle cells are separated by slits containing red blood cells in lymph node with 
Kaposi’s sarcoma (hematoxylin and eosin stain, ×200) (a), anti-HHV-8 antibody immunostaining 
positivity detected in the lymph node (×400) (b). 
 
 
 
Fig. 2. Peripheral blood film showing atypical lymphoid cells with surface projections – ‘hairy cells’ 
(Giemsa stain, ×1,000). 
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Fig. 3. The bone marrow is markedly hypercellular due to interstitial and diffuse infiltration of hairy 
cells (hematoxylin and eosin stain, ×400) (a), the hairy cells are intensely reactive with CD20 (×200) (b). 
Reticulin stain of the bone marrow biopsy shows a moderate increase in reticulin fibers, and the 
reticulin fibers appear to individually circumscribe the hairy cells (×400) (c). Tartrate-resistant acid 
phosphatase (TRAP) positivity was detected in the bone marrow (×400) (d). 
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